Arterial hypertension and renal allograft survival
- PMID: 10665703
- DOI: 10.1001/jama.283.5.633
Arterial hypertension and renal allograft survival
Abstract
Context: Several observational studies have investigated the significance of hypertension in renal allograft failure; however, these studies have been complicated by the lack of adjustment for baseline renal function, leaving the role of elevated blood pressure in allograft failure unclear.
Objective: To examine the relationship between blood pressure adjusted for renal function and survival after cadaveric allograft transplantation.
Design: Nonconcurrent historical cohort study conducted from 1985 through 1997.
Setting: University teaching hospital.
Participants: A total of 277 patients aged 18 years or older who underwent cadaveric renal transplantation without another simultaneous organ transplantation and whose allograft was functioning for a minimum of 1 year. Follow-up continued through 1997 (mean follow-up, 5.7 years).
Main outcome measure: Time to allograft failure (defined as death, return to dialysis, or retransplantation) by systolic, diastolic, and mean arterial blood pressure measurements at 1 year after transplantation.
Results: Multivariate Cox proportional hazards modeling demonstrated that nonwhite ethnicity, history of acute rejection, and nondiabetic kidney disease were significant predictors of failure (P = .01 for all). In addition, the calculated creatinine clearance at 1 year had an adjusted rate ratio (RR) for allograft failure per 10 mL/min (0.17 mL/s) of 0.74 (95% confidence interval [CI], 0.62-0.88). The RR per 10-mm Hg increase in blood pressure measured at 1 year after transplantation, after adjustment for creatinine clearance, was 1.15 (95% CI, 1.02-1.30) for systolic pressure, 1.27 (95% CI, 1.01-1.60) for diastolic pressure, and 1.30 (95% CI, 1.05-1.61) for mean arterial pressure. Supplemental analyses that did not include death as a failure event or reduce the minimum allograft survival time for study subjects to 6 months yielded results consistent with the primary analysis. There was no evidence of modification of the blood pressure-allograft failure relationship by ethnicity or diabetes mellitus.
Conclusions: Systolic, diastolic, and mean arterial blood pressures at 1 year posttransplantation strongly predict allograft survival adjusted for baseline renal function. More aggressive control of blood pressure may prolong cadaveric allograft survival.
Similar articles
-
Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.J Pediatr. 2003 Jul;143(1):98-103. doi: 10.1016/S0022-3476(03)00209-9. J Pediatr. 2003. PMID: 12915832
-
Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.Transplant Proc. 2009 Jul-Aug;41(6):2151-5. doi: 10.1016/j.transproceed.2009.06.134. Transplant Proc. 2009. PMID: 19715859
-
Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate.Nephrol Dial Transplant. 2001;16 Suppl 1:105-9. doi: 10.1093/ndt/16.suppl_1.105. Nephrol Dial Transplant. 2001. PMID: 11369835
-
Impact of renal allograft nephrectomy on graft and patient survival following retransplantation: a systematic review and meta-analysis.Nephrol Dial Transplant. 2018 Apr 1;33(4):700-708. doi: 10.1093/ndt/gfx360. Nephrol Dial Transplant. 2018. PMID: 29444290
-
Patient and renal allograft survival in the late posttransplant period.Semin Nephrol. 1992 Jul;12(4):343-52. Semin Nephrol. 1992. PMID: 1410862 Review.
Cited by
-
The impact of diabetes and hypertension on renal allograft survival- A single center study.Curr Urol. 2023 Dec;17(4):286-291. doi: 10.1097/CU9.0000000000000068. Epub 2022 Aug 2. Curr Urol. 2023. PMID: 37994332 Free PMC article.
-
Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients.Pediatr Nephrol. 2004 Nov;19(11):1202-11. doi: 10.1007/s00467-004-1601-2. Pediatr Nephrol. 2004. PMID: 15365804 Review.
-
Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial.JMIR Res Protoc. 2013 Sep 4;2(2):e32. doi: 10.2196/resprot.2633. JMIR Res Protoc. 2013. PMID: 24004517 Free PMC article.
-
Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?Pediatr Nephrol. 2021 Mar;36(3):539-549. doi: 10.1007/s00467-020-04485-8. Epub 2020 Feb 14. Pediatr Nephrol. 2021. PMID: 32060819
-
Patient experiences with self-monitoring renal function after renal transplantation: results from a single-center prospective pilot study.Patient Prefer Adherence. 2015 Dec 7;9:1721-31. doi: 10.2147/PPA.S92108. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26673985 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical